Faster access than browser!Similarities between Hallucinogen and Psychopharmacology
Hallucinogen and Psychopharmacology have 30 things in common (in Unionpedia): Agonist, Amanita muscaria, Ancient Greek, Cannabinoid receptor type 1, Cannabis (drug), Chemical synthesis, Cyclic adenosine monophosphate, Depressant, Hallucinogen, Lysergic acid diethylamide, Mescaline, Methamphetamine, Monoamine oxidase inhibitor, Muscimol, Mushroom, N,N-Dimethyltryptamine, Neurotransmitter, Nicotine, Opioid, Over-the-counter drug, Parkinson's disease, Psilocybin, Psychiatry, Psychoactive drug, Receptor antagonist, Recreational drug use, Schizophrenia, Serotonin, Synaptic vesicle, Tryptamine.
Agonist
An agonist is a chemical that binds to a receptor and activates the receptor to produce a biological response.
Agonist and Hallucinogen · Agonist and Psychopharmacology ·
Amanita muscaria
Amanita muscaria, commonly known as the fly agaric or fly amanita, is a basidiomycete mushroom, one of many in the genus Amanita.
Amanita muscaria and Hallucinogen · Amanita muscaria and Psychopharmacology ·
Ancient Greek
The Ancient Greek language includes the forms of Greek used in ancient Greece and the ancient world from around the 9th century BC to the 6th century AD.
Ancient Greek and Hallucinogen · Ancient Greek and Psychopharmacology ·
Cannabinoid receptor type 1
The cannabinoid type 1 receptor, often abbreviated as CB1, is a G protein-coupled cannabinoid receptor located in the central and peripheral nervous system.
Cannabinoid receptor type 1 and Hallucinogen · Cannabinoid receptor type 1 and Psychopharmacology ·
Cannabis (drug)
Cannabis, also known as marijuana among other names, is a psychoactive drug from the ''Cannabis'' plant intended for medical or recreational use.
Cannabis (drug) and Hallucinogen · Cannabis (drug) and Psychopharmacology ·
Chemical synthesis
Chemical synthesis is a purposeful execution of chemical reactions to obtain a product, or several products.
Chemical synthesis and Hallucinogen · Chemical synthesis and Psychopharmacology ·
Cyclic adenosine monophosphate
Cyclic adenosine monophosphate (cAMP, cyclic AMP, or 3',5'-cyclic adenosine monophosphate) is a second messenger important in many biological processes.
Cyclic adenosine monophosphate and Hallucinogen · Cyclic adenosine monophosphate and Psychopharmacology ·
Depressant
A depressant, or central depressant, is a drug that lowers neurotransmission levels, which is to depress or reduce arousal or stimulation, in various areas of the brain.
Depressant and Hallucinogen · Depressant and Psychopharmacology ·
Hallucinogen
A hallucinogen is a psychoactive agent which can cause hallucinations, perceptual anomalies, and other substantial subjective changes in thoughts, emotion, and consciousness.
Hallucinogen and Hallucinogen · Hallucinogen and Psychopharmacology ·
Lysergic acid diethylamide
Lysergic acid diethylamide (LSD), also known as acid, is a psychedelic drug known for its psychological effects, which may include altered awareness of one's surroundings, perceptions, and feelings as well as sensations and images that seem real though they are not.
Hallucinogen and Lysergic acid diethylamide · Lysergic acid diethylamide and Psychopharmacology ·
Mescaline
Mescaline (3,4,5-trimethoxyphenethylamine) is a naturally occurring psychedelic alkaloid of the phenethylamine class, known for its hallucinogenic effects comparable to those of LSD and psilocybin.
Hallucinogen and Mescaline · Mescaline and Psychopharmacology ·
Methamphetamine
Methamphetamine (contracted from) is a potent central nervous system (CNS) stimulant that is mainly used as a recreational drug and less commonly as a second-line treatment for attention deficit hyperactivity disorder and obesity.
Hallucinogen and Methamphetamine · Methamphetamine and Psychopharmacology ·
Monoamine oxidase inhibitor
Monoamine oxidase inhibitors (MAOIs) are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B).
Hallucinogen and Monoamine oxidase inhibitor · Monoamine oxidase inhibitor and Psychopharmacology ·
Muscimol
Muscimol (also known as agarin or pantherine) is one of the principal psychoactive constituents of Amanita muscaria and related species of mushroom.
Hallucinogen and Muscimol · Muscimol and Psychopharmacology ·
Mushroom
A mushroom, or toadstool, is the fleshy, spore-bearing fruiting body of a fungus, typically produced above ground on soil or on its food source.
Hallucinogen and Mushroom · Mushroom and Psychopharmacology ·
N,N-Dimethyltryptamine
N,N-Dimethyltryptamine (DMT or N,N-DMT) is a tryptamine molecule which occurs in many plants and animals.
Hallucinogen and N,N-Dimethyltryptamine · N,N-Dimethyltryptamine and Psychopharmacology ·
Neurotransmitter
Neurotransmitters are endogenous chemicals that enable neurotransmission.
Hallucinogen and Neurotransmitter · Neurotransmitter and Psychopharmacology ·
Nicotine
Nicotine is a potent parasympathomimetic stimulant and an alkaloid found in the nightshade family of plants.
Hallucinogen and Nicotine · Nicotine and Psychopharmacology ·
Opioid
Opioids are substances that act on opioid receptors to produce morphine-like effects.
Hallucinogen and Opioid · Opioid and Psychopharmacology ·
Over-the-counter drug
Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
Hallucinogen and Over-the-counter drug · Over-the-counter drug and Psychopharmacology ·
Parkinson's disease
Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.
Hallucinogen and Parkinson's disease · Parkinson's disease and Psychopharmacology ·
Psilocybin
Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.
Hallucinogen and Psilocybin · Psilocybin and Psychopharmacology ·
Psychiatry
Psychiatry is the medical specialty devoted to the diagnosis, prevention and treatment of mental disorders.
Hallucinogen and Psychiatry · Psychiatry and Psychopharmacology ·
Psychoactive drug
A psychoactive drug, psychopharmaceutical, or psychotropic is a chemical substance that changes brain function and results in alterations in perception, mood, consciousness, cognition, or behavior.
Hallucinogen and Psychoactive drug · Psychoactive drug and Psychopharmacology ·
Receptor antagonist
A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist.
Hallucinogen and Receptor antagonist · Psychopharmacology and Receptor antagonist ·
Recreational drug use
Recreational drug use is the use of a psychoactive drug to induce an altered state of consciousness for pleasure, by modifying the perceptions, feelings, and emotions of the user.
Hallucinogen and Recreational drug use · Psychopharmacology and Recreational drug use ·
Schizophrenia
Schizophrenia is a mental disorder characterized by abnormal social behavior and failure to understand reality.
Hallucinogen and Schizophrenia · Psychopharmacology and Schizophrenia ·
Serotonin
Serotonin or 5-hydroxytryptamine (5-HT) is a monoamine neurotransmitter.
Hallucinogen and Serotonin · Psychopharmacology and Serotonin ·
Synaptic vesicle
In a neuron, synaptic vesicles (or neurotransmitter vesicles) store various neurotransmitters that are released at the synapse.
Hallucinogen and Synaptic vesicle · Psychopharmacology and Synaptic vesicle ·
Tryptamine
Tryptamine is a monoamine alkaloid.
Hallucinogen and Tryptamine · Psychopharmacology and Tryptamine ·
The list above answers the following questions
- What Hallucinogen and Psychopharmacology have in common
- What are the similarities between Hallucinogen and Psychopharmacology
Hallucinogen and Psychopharmacology Comparison
Hallucinogen has 216 relations, while Psychopharmacology has 138. As they have in common 30, the Jaccard index is 8.47% = 30 / (216 + 138).
References
This article shows the relationship between Hallucinogen and Psychopharmacology. To access each article from which the information was extracted, please visit:
